Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease.

Front Immunol · 2022 · PMC9714556 · PMID 36466922

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although MSCs have extensively been used in clinical trials for GVHD therapy and have shown some efficacy, some studies did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.